LA JOLLA—Regulatory T cells (Tregs) are the traffic cops of the immune system. They instruct other types of immune cells on when to stop and when to go. Learning how to direct the activity of Tregs has important implications for improving cancer immunotherapy as well as developing better treatments for autoimmune diseases such as rheumatoid arthritis and type 1 diabetes.
LA JOLLA—Salk Institute scientists will lead a multimillion-dollar, five-year initiative to revolutionize our understanding of the human brain by systematically identifying and cataloging cell types across the mammalian brain, the National Institutes of Health has announced. The effort, which is part of the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative®, will be co-led by Salk Professors Joseph Ecker and Ed Callaway. Researchers from USC and UC San Diego will also participate in the collaboration.
LA JOLLA—Sensory neurons regulate how we recognize pain, touch, and the movement and position of our own bodies, but the field of neuroscience is just beginning to unravel this circuitry. Now, new research from the Salk Institute shows how a protein called p75 is critical for pain signaling, which could one day have implications for treating neurological disorders as well as trauma such as spinal cord injury.
LA JOLLA—The Salk Institute has been named the recipient of two awards, including the top honor, by the California Preservation Foundation for the restoration of its teak window systems and establishment of an endowment for future conservation projects. The awards were presented at the 34th annual Preservation Design Awards & President’s Awards ceremony on October 13, 2017, at the InterContinental Mark Hopkins Hotel in San Francisco.
LA JOLLA—Salk Professor and HHMI Investigator Ronald Evans has been awarded $2.5 million by Stand Up To Cancer (SU2C) as part of a multi-institution team to conduct clinical studies to open up a new avenue for immunotherapy in the treatment of pancreatic cancer. While the cancer normally excludes immune T-cells, the Evans lab discovered that modified vitamin D reprograms the cancer environment in a way that may allow the Merck drug Keytruda® to invade and destroy the tumor.
LA JOLLA—To have a good phone conversation, you need a good cellular connection. What's true for mobile phones also turns out to be true for neurons.
LA JOLLA—Salk Institute Assistant Professor Eiman Azim has been named an NIH Director’s New Innovator for 2017 as part of the National Institutes of Health’s High-Risk, High-Reward Research Program. The award provides $1.5 million for a 5-year project during which Azim will explore how the nervous system controls dexterous movements.
LA JOLLA—The Salk Institute announced that total revenues in fiscal year 2017 (July 1, 2016 to June 30, 2017) rose to $134 million from $118 million the previous fiscal year, a 13.5 percent increase. Nearly half of the revenues, $62 million, came from donors, including foundation gifts and grants, and individual gifts and bequests. The balance came from government and corporate funding and investment income.
Salk President Elizabeth Blackburn was invited to present the keynote address at the University of Queensland last month on gender equity and diversity issues in the Science, Technology, Engineering, Mathematics and Medicine (STEMM) disciplines. Blackburn is Australia’s first female Nobel laureate. Following her address, which received a positive audience response, she participated in a panel discussion on the barriers and challenges of women in science. Here is a transcript of her address:
LA JOLLA—Silvana Konermann, a research associate in the lab of Helmsley-Salk Fellow Patrick Hsu, was chosen as one of 15 inaugural Howard Hughes Medical Institute Hanna H. Gray Fellows. Each fellow will receive up to $1.4 million in funding over eight years.
LA JOLLA—Is it better to do a task quickly and make mistakes, or to do it slowly but perfectly? When it comes to deciding how to fix breaks in DNA, cells face the same choice between two major repair pathways. The decision matters, because the wrong choice could cause even more DNA damage and lead to cancer.
LA JOLLA—The immune system automatically destroys dysfunctional cells such as cancer cells, but cancerous tumors often survive nonetheless. A new study by Salk scientists shows one method by which fast-growing tumors evade anti-tumor immunity.
LA JOLLA—Salk Institute scientists have discovered that an interaction between two key proteins helps regulate and maintain the cells that produce neurons. The work, published in Cell Stem Cell on September 14, 2017, offers insight into why an imbalance between these precursor cells and neurons might contribute to mental illness or age-related brain disease.
LA JOLLA—Salk Institute President Elizabeth Blackburn—the Institute’s first female president and one of only 12 women to have won a Nobel Prize in Physiology or Medicine—is among 46 honorees featured in FIRSTS, a new TIME multimedia project celebrating “women who broke ground in their fields” and “played pioneers in history,” the Salk Institute announced today.
LA JOLLA—Salk Associate Professor Tatyana Sharpee has been awarded a grant of approximately $950,000 over 4 years by the National Science Foundation to study how the brain processes complex sounds. This grant is part of a multi-national project together with groups in France and Israel.
LA JOLLA—It may seem paradoxical, but studying what goes wrong in rare diseases can provide useful insights into normal health. Researchers probing the premature aging disorder Hutchinson-Gilford progeria have uncovered an errant protein process in the disease that could help healthy people as well as progeria sufferers live longer.
LA JOLLA—Under a microscope, it can be hard to tell the difference between any two neurons, the brain cells that store and process information. So scientists have turned to molecular methods to try to identify groups of neurons with different functions.
LA JOLLA—As part of the National Science Foundation’s funding for new multidisciplinary approaches to neuroscience, Salk Professor Terrence Sejnowski together with the California Institute of Technology will receive over $1 million over 3 years to pursue advanced modeling of the brain.
LA JOLLA—Scientists have, for the first time, corrected a disease-causing mutation in early stage human embryos with gene editing. The technique, which uses the CRISPR-Cas9 system, corrected the mutation for a heart condition at the earliest stage of embryonic development so that the defect would not be passed on to future generations.
LA JOLLA—Two Salk neuroscience labs are part of a National Science Foundation (NSF) effort to better understand the brain. Salk Professors Terrence Sejnowski and Ed Callaway are each collaborators in multi-institute projects awarded over $9 million apiece.
Your partnership allows our scientists to accelerate the pace of high-risk, high-reward discoveries that have the potential to benefit the health of all humanity-be it cancer, Alzheimer’s disease, climate change, infectious diseases or more.
